Isan Chen

EVP, Chief Medical Officer at Mirati Therapeutics, Inc.

Filed with the SEC as CHEN ISAN

Sold, on record
$3.5M
Dollars the filings state
Form 4 sales
1
Latest May 11, 2020
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. May 11, 2020Unusual

    Mirati Therapeutics, Inc.

    Sold 45.8% of their holdings

    $3.5M33,334 shares at $105.00

    Filed May 13, 2020Form 4

1 of 1

Every transaction

Every transaction on a Form 4 or Form 5 by Isan Chen
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
May 31, 2023Jun 2, 2023TYRADirectorAwardedStock Option (Right to Buy)14,50014,500SEC
Jun 13, 2022Jun 15, 2022TYRADirectorAwardedStock Option (Right to Buy)14,50014,500SEC
Sep 17, 2021Sep 17, 2021TYRADirectorConvertedSeries A Preferred Stock23,6560SEC
Sep 17, 2021Sep 17, 2021TYRADirectorConverted61,444192,783SEC
May 11, 2020May 13, 2020Mirati Therapeutics, Inc.EVP, Chief Medical OfficerSold33,334$105.00$3.5M39,401SEC
May 11, 2020May 13, 2020Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised or settledStock Options33,33423,420SEC
May 11, 2020May 13, 2020Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised options33,334$24.99$833k72,735SEC
Jan 29, 2020Jan 31, 2020Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised or settledStock Options3,00256,754SEC
Jan 29, 2020Jan 31, 2020Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised options3,002$24.99$75k39,401SEC
Jan 23, 2019Jan 25, 2019Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised or settledStock Options87049,997SEC
Jan 23, 2019Jan 25, 2019Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised options870$22.47$20k35,836SEC
Jan 17, 2019Jan 22, 2019Mirati Therapeutics, Inc.EVP, Chief Medical OfficerAwardedOption Grant (Right to Buy)60,00060,000SEC
Jul 16, 2018Jul 17, 2018Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised or settledEmployee Stock Option (Right to Buy)1,86725,908SEC
Jul 16, 2018Jul 17, 2018Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised options1,867$20.91$39k34,582SEC
Apr 25, 2018Apr 26, 2018Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised or settledEmployee Stock Option (Right to Buy)13,03827,500SEC
Apr 25, 2018Apr 26, 2018Mirati Therapeutics, Inc.EVP, Chief Medical OfficerExercised options13,038$16.94$221k31,836SEC
Jan 18, 2018Jan 22, 2018Mirati Therapeutics, Inc.EVP, Chief Medical OfficerAwardedOption Grant (Right to Buy)50,00050,000SEC
Jan 26, 2017Jan 30, 2017Mirati Therapeutics, Inc.Sr. VP, Chief MedicalAwardedOption Grant (Right to Buy)50,00050,000SEC
Jan 22, 2016Jan 26, 2016Mirati Therapeutics, Inc.Sr. Vice President, Chief MediAwardedStock Options60,00060,000SEC
Jan 13, 2016Jan 15, 2016Mirati Therapeutics, Inc.Sr.Vice President, Chief MediExercised or settledIncentive Stock Option (right to buy)2,542106,792SEC
Jan 13, 2016Jan 15, 2016Mirati Therapeutics, Inc.Sr.Vice President, Chief MediExercised options2,542$15.79$40k18,113SEC
Mar 9, 2015Mar 11, 2015Mirati Therapeutics, Inc.Chief Medical & Dev't OfficerExercised or settledEmployee Stock Option (Right to Buy)12,666109,334SEC
Mar 9, 2015Mar 11, 2015Mirati Therapeutics, Inc.Chief Medical & Dev't OfficerExercised options12,666$15.79$200k12,666SEC
Feb 4, 2015Feb 5, 2015Mirati Therapeutics, Inc.Chief Medical & Dev't OfficerAwardedEmployee Stock Option (Right to Buy)30,00030,000SEC
May 21, 2014May 23, 2014Mirati Therapeutics, Inc.Chief Medical & Dev't OfficerAwardedEmployee Stock Option (Right to Buy)6,6006,600SEC
Nov 8, 2013Nov 12, 2013Mirati Therapeutics, Inc.Chief Medical & Dev't OfficerAwardedEmployee Stock Option (Right to Buy)122,000122,000SEC

Sales and notices (1)

Form 144 notices and Form 4 sales by Isan Chen
Source
May 11, 2020May 13, 2020Mirati Therapeutics, Inc.EVP, Chief Medical OfficerForm 4 sale33,334$3.5M45.8%UnusualSEC